Accor S. A. (AC)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 44.53 |
|---|---|
| 52-week range | 37.54 – 52.00 |
| Return, 1 month / 3 months | −3.3% / −1.9% |
| Return, 1 year / 3 years | +8.6% / +63.1% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 28.5% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 30.93M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Accor is a French hospitality group based in Paris that operates hotels and resorts around the world. Its brands span budget to upscale segments, including Ibis, Novotel, Mercure and Sofitel, and it also offers related services such as dining, meetings and loyalty programmes. The company works with hotel owners through franchise and management arrangements as well as operating some properties itself, serving business and leisure travellers in many countries.
Accor S. A. trades under the code AC on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Accor S. A. (AC) trades on the Euronext Paris in France. It last closed at EUR 44.53 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 65 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.6% and over the last three months it fell 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.5% | ||
| From 52-week high | -13.7% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -1.9% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | 12.3% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 30.93M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −3.3% |
| 3 months | −1.9% |
| 6 months | +6.3% |
| 1 year | +8.6% |
| 3 years | +63.1% |
| 5 years | +67.5% |
Signals
| 50-day / 200-day average | 45.83 / 45.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | EUR 1.3500 |
| 2 Jun 2025 | EUR 1.2600 |
| 5 Jun 2024 | EUR 1.1800 |
| 23 May 2023 | EUR 1.0500 |
| 10 May 2019 | EUR 1.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.